Details
Stereochemistry | ACHIRAL |
Molecular Formula | 2C14H19N3S.3C4H4O4 |
Molecular Weight | 870.988 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 3 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)\C=C\C(O)=O.OC(=O)\C=C\C(O)=O.OC(=O)\C=C\C(O)=O.CN(C)CCN(CC1=CC=CS1)C2=CC=CC=N2.CN(C)CCN(CC3=CC=CS3)C4=CC=CC=N4
InChI
InChIKey=OLGIEIJNOQGBSS-VQYXCCSOSA-N
InChI=1S/2C14H19N3S.3C4H4O4/c2*1-16(2)9-10-17(12-13-6-5-11-18-13)14-7-3-4-8-15-14;3*5-3(6)1-2-4(7)8/h2*3-8,11H,9-10,12H2,1-2H3;3*1-2H,(H,5,6)(H,7,8)/b;;3*2-1+
Molecular Formula | C14H19N3S |
Molecular Weight | 261.386 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C4H4O4 |
Molecular Weight | 116.0722 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
DescriptionSources: http://www.drugbank.ca/drugs/DB04819
Sources: http://www.drugbank.ca/drugs/DB04819
Methapyrilene is an antihistamine and anticholinergic of the pyridine chemical class which was developed in the early 1950s. It was sold under the trade names Co-Pyronil and Histadyl EC. It has relatively strong sedative effects, to the extent that its primary use was as a medication for insomnia rather than for its antihistamine action. Together with scopolamine, it was the main ingredient in Sominex, Nytol, and Sleep-Eze. It also provided the sedative component of Excedrin PM. Manufacturers voluntarily withdrew methapyrilineb drug products from the market in May and June 1979, when methapyrilene was demonstrated to cause liver cancer in rats when given chronically.
Approval Year
Doses
Dose | Population | Adverse events |
---|---|---|
2.5 g single, oral Overdose |
healthy, 19 years |
Other AEs: Dizziness, Stomach cramps... |
25 mg single, intravenous Dose: 25 mg Route: intravenous Route: single Dose: 25 mg Sources: |
healthy, 20 - 35 years Health Status: healthy Age Group: 20 - 35 years Sex: M+F Sources: |
|
50 mg single, oral |
healthy, 20 - 35 years Health Status: healthy Age Group: 20 - 35 years Sex: M+F Sources: |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Delusions | 2.5 g single, oral Overdose |
healthy, 19 years |
|
Dizziness | 2.5 g single, oral Overdose |
healthy, 19 years |
|
Stomach cramps | 2.5 g single, oral Overdose |
healthy, 19 years |
PubMed
Title | Date | PubMed |
---|---|---|
Effects of induction and inhibition of cytochromes P450 on the hepatotoxicity of methapyrilene. | 1998 Nov |
|
Principal component analysis of mass spectra of peptides generated from the tryptic digestion of protein mixtures. | 2001 |
|
Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. | 2001 Mar 31 |
|
Fluorescence polarization discriminates green fluorescent protein from interfering autofluorescence in a microplate assay for genotoxicity. | 2002 Apr 18 |
|
Quantitative PCR deconstruction of discrepancies between results reported by different hybridization platforms. | 2004 Mar |
|
Cross-site comparison of gene expression data reveals high similarity. | 2004 Mar |
|
Interlaboratory evaluation of rat hepatic gene expression changes induced by methapyrilene. | 2004 Mar |
|
Gene expression analysis of the hepatotoxicant methapyrilene in primary rat hepatocytes: an interlaboratory study. | 2006 Jan |
|
Toxicophores: investigations in drug safety. | 2006 Sep 1 |
|
Literature-based compound profiling: application to toxicogenomics. | 2007 Nov |
|
Gene expression profiling of rat liver treated with serum triglyceride-decreasing compounds. | 2007 Oct |
|
Identification of the thiophene ring of methapyrilene as a novel bioactivation-dependent hepatic toxicophore. | 2008 Aug |
|
Gene expression profiling of methapyrilene-induced hepatotoxicity in rat. | 2008 Feb |
|
Functional and toxicological consequences of metabolic bioactivation of methapyrilene via thiophene S-oxidation: Induction of cell defence, apoptosis and hepatic necrosis. | 2009 Sep 15 |
|
Characterization of glutathione conjugates of duloxetine by mass spectrometry and evaluation of in silico approaches to rationalize the site of conjugation for thiophene containing drugs. | 2010 Aug 16 |
|
The genotoxic potential of methapyrilene using the alkaline Comet assay in vitro and in vivo. | 2011 Dec 18 |
|
Comparison of hepatocarcinogen-induced gene expression profiles in conventional primary rat hepatocytes with in vivo rat liver. | 2012 Sep |
|
Detection of initiating potential of non-genotoxic carcinogens in a two-stage hepatocarcinogenesis study in rats. | 2014 |
|
Changes in the expression of miRNAs at the pericentral and periportal regions of the rat liver in response to hepatocellular injury: comparison with the changes in the expression of plasma miRNAs. | 2014 Aug 1 |
|
Assessment of global and gene-specific DNA methylation in rat liver and kidney in response to non-genotoxic carcinogen exposure. | 2015 Dec 1 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/2046705
Methapyrilene failed to induce formation of DNA adducts in L5178Y cell DNA at doses which induced mutations at the thymidine kinase locus. These data suggest that methapyrilene induces mutations in this system through an indirect genotoxic mechanism; e.g., via an oxidative mechanism or interaction with chromosomal proteins.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:01:18 UTC 2023
by
admin
on
Fri Dec 15 15:01:18 UTC 2023
|
Record UNII |
KJ5I25TXYL
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Fri Dec 15 15:01:18 UTC 2023 , Edited by admin on Fri Dec 15 15:01:18 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
33032-12-1
Created by
admin on Fri Dec 15 15:01:18 UTC 2023 , Edited by admin on Fri Dec 15 15:01:18 UTC 2023
|
PRIMARY | |||
|
SUB14535MIG
Created by
admin on Fri Dec 15 15:01:18 UTC 2023 , Edited by admin on Fri Dec 15 15:01:18 UTC 2023
|
PRIMARY | |||
|
C83953
Created by
admin on Fri Dec 15 15:01:18 UTC 2023 , Edited by admin on Fri Dec 15 15:01:18 UTC 2023
|
PRIMARY | |||
|
KJ5I25TXYL
Created by
admin on Fri Dec 15 15:01:18 UTC 2023 , Edited by admin on Fri Dec 15 15:01:18 UTC 2023
|
PRIMARY | |||
|
m7301
Created by
admin on Fri Dec 15 15:01:18 UTC 2023 , Edited by admin on Fri Dec 15 15:01:18 UTC 2023
|
PRIMARY | Merck Index | ||
|
100000076549
Created by
admin on Fri Dec 15 15:01:18 UTC 2023 , Edited by admin on Fri Dec 15 15:01:18 UTC 2023
|
PRIMARY | |||
|
251-351-3
Created by
admin on Fri Dec 15 15:01:18 UTC 2023 , Edited by admin on Fri Dec 15 15:01:18 UTC 2023
|
PRIMARY | |||
|
CHEMBL1411979
Created by
admin on Fri Dec 15 15:01:18 UTC 2023 , Edited by admin on Fri Dec 15 15:01:18 UTC 2023
|
PRIMARY | |||
|
DTXSID0047404
Created by
admin on Fri Dec 15 15:01:18 UTC 2023 , Edited by admin on Fri Dec 15 15:01:18 UTC 2023
|
PRIMARY | |||
|
6436730
Created by
admin on Fri Dec 15 15:01:18 UTC 2023 , Edited by admin on Fri Dec 15 15:01:18 UTC 2023
|
PRIMARY | |||
|
DBSALT002793
Created by
admin on Fri Dec 15 15:01:18 UTC 2023 , Edited by admin on Fri Dec 15 15:01:18 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |